Timothy Cannon is an Oncology physician affiliated with Inova Health System. OpenAlex indexes 118 publications with 5,219 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8081 Innovation Park Dr
Fairfax, VA 220314867
Telephone
571-472-4724Provider last certified this registry record 10 Sept 2021.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20251 payment
- Mirati Therapeutics, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
35.3%Serotonin-3 Receptor Antagonist11.5%Ondansetron Hcl78%Ondansetron Odt22%Part D<11 patientsAntidiarrheal microorganisms6.6%Creon100%Part D≥14 patients+ 7 more classes in this area
Nervous system
18.3%Atypical Antipsychotic6.7%Olanzapine100%Part D≥23 patientsPhenothiazine5%Prochlorperazine Maleate100%Part D≥33 patients+ 3 more classes in this area
Blood & clotting
11.9%Factor Xa inhibitor11.9%Eliquis87%Xarelto13%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Garima Sharma, MBBS
Inova Health System
Wayne Batchelor, MD
Inova Health System
Kei Suzuki, MD
Inova Health System
Mateo Ziu, MD
Inova Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”